Glenmark has struck a deal with private equity firm True North for its gynecology business in India and Nepal.
Integrace Private Limited, a portfolio company of the private equity firm True North, has snapped up Glenmark’s gynecology business in India and Nepal for INR1.15bn ($16.1m).
The deal includes established Glenmark brands such as Dubagest (progesterone), Fenza (fenticonazole), Milical (calcium citrate/cholecalciferol) and iron deficiency anaemia therapy...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
